Pseudomonas Cepacia Typing Systems: Collaborative Study to Assess their Potential in Epidemiologic Investigations

Reviews of Infectious Diseases

Volumn 11, Issue 4, 1989, Pages 600-607

  Rabkin, Charles S ^a   Jarvis, William R ^b   Anderson, Roger L ^c   Govan, John ^c   Klinger, Jeffrey ^d   Lipuma, John ^d   Martone, William J ^e   Monteil, H ^e   Richard, C ^f   Shigeta, Shiro ^f   Sosa, Anibal ^g   Stull, Terrence ^g   Swenson, Jana ^h   Woods, Donald ^h  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c Integrated Genetics   (United States)

^d DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^e UNIVERSITÉ DE STRASBOURG   (France)

^f INSTITUT PASTEUR   (France)

^g FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^h Health Sciences Centre Calgary   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIAL CHROMOSOME; CLASSIFICATION; GENETICS; GRAM NEGATIVE INFECTION; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; PSEUDOMONAS; SEROTYPING;

CHROMOSOMES, BACTERIAL; HUMAN; MICROBIAL SENSITIVITY TESTS; PSEUDOMONAS; PSEUDOMONAS INFECTIONS; SEROTYPING;

EID: 0024694307     PISSN: 01620886     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinids/11.4.600     Document Type: Article

References (32)

1. Berkelman RL, Godley J, Weber JA, Anderson RL, Lerner AM, Petersen NJ, Allen JR, the Investigative Team. Pseudomonas cepacia Typing Systems 607 domonas cepacia peritonitis associated with contamination of automatic peritoneal dialysis machines. Ann Intern Med 1982; 96: 456-8
2. Weinstein RA, Emori TG, Anderson RL, Stamm WE. Pressure transducers as a source of bacteremia after open heart surgery. Report of an outbreak and guidelines for prevention. Chest 1976; 69: 338-43
3. Centers for Disease Control. Pseudomonas cepacia colonization —Minnesota. MMWR 1981; 30: 610-1
4. Berkelman RL, Lewin S, Allen JR, Anderson RL, Budnick, LD, Shapiro S, Friedman SM, Nicholas P, Holzman RS, Haley RW. Pseudobacteremia attributed to contamination of povidone-iodine with Pseudomonas cepacia. Ann Intern Med 1981; 95: 32-6
5. Steere AC, Tenney JH, Mackel DC, Snyder MJ, Polakavetz, S, Dunne ME, Dixon RE. Pseudomonas species bacteremia caused by contaminated normal and human serum albumin. J Infect Dis 1977; 135: 729-35
6. Sobel JD, Hashman N, Reinherz G, Merzbach D. Nosocomial Pseudomonas cepacia infection associated with Chlorhexidine contamination. Am J Med 1982; 73: 183-6
7. Carson LA, Favero MS, Bond WW, Petersen NJ. Morphological, biochemical, and growth characteristics of Pseudomonas cepacia from distilled water. Appl Microbiol 1973; 25: 476-83
8. Dixon RE, Kaslow RA, Mackel DC, Fulkerson CC, Mallison GF. Aqueous quaternary ammonium antiseptics and disinfectants: use and misuse. JAMA 1976; 236: 2415-7
9. Frank MJ, Schaffner W. Contaminated aqueous benzalko- nium chloride: an unnecessary hospital infection hazard. JAMA 1976; 236: 2418-9
10. Marione WJ, Osterman CA, Fisher KA, Wenzel RP. Pseudomonas cepacia: implications and control of epidemic nosocomial colonization. Rev Infect Dis 1981; 3: 708-15
11. Conly JM, Klass L, Larson L, Kennedy J, Low DE, Harding GKM. Pseudomonas cepacia colonization and infection in intensive care units. Can Med Assoc J 1986; 134: 363-6
12. Stover GB, Drake DR, Montie TC. Virulence of different Pseudomonas species in a burned mouse model: tissue colonization by Pseudomonas cepacia. Infect Immun 1983; 41: 1099-104
13. Isles A, Maclusky I, Corey M, Gold R, Prober C, Fleming P, Levison H. Pseudomonas cepacia infection in cystic fibrosis: an emerging problem. J Pediatr 1984; 104: 206-10
14. Tablan OC, Chorba TL, Schidlow DV, White JW, Hardy KA, Gilligan PH, Morgan WM, Carson LA, Martone WJ, Jason JM, Jarvis WR. Pseudomonas cepacia colonization in patients with cystic fibrosis: risk factors and clinical outcome. J Pediatr 1985; 107: 382-7
15. Rabkin CS, Jarvis WR, Martone WJ. Current status of Pseudomonas cepacia typing systems. Eur J Epidemiol 1987; 3: 343-6
16. Jonsson V. Studies to characterize the gram-negative bacilli designated as eugonic oxidizers group number one [Diss]. Chapel Hill, NC: University of North Carolina, 1965
17. Klinger JD, Bajaksouzian S, Klayman S. Pseudomonas cepacia in cystic fibrosis patients [abstract]. Cystic Fibrosis Club Abstracts 1986; 27: 115
18. Heidt A, Monteil H, Richard C. O and H serotyping of Pseudomonas cepacia. J Clin Microbiol 1983; 18: 738-40
19. Nakamura Y, Hyodo S, Chonan E, Shigeta S, Yabuuchi E. Serological classification of Pseudomonas cepacia by somatic antigen. J Clin Microbiol 1986; 24: 152-4
20. McKevitt AI, Retzer MD, Woods DE. Development and use of a serotyping scheme for Pseudomonas cepacia. Serodi- agnosis Immunotherapy 1987; 1: 177-84
21. Gonzalez CF, Vidaver AK. Bacteriocin, plasmid and pectolytic diversity in Pseudomonas cepacia of clinical and plant origin. J Gen Microbiol 1979; 110: 161-70
22. Govan JRW, Harris G. Typing of Pseudomonas cepacia by bacteriocin susceptibility and production. J Clin Microbiol 1985; 22: 490-4
23. McKevitt AI, Woods DE. Characterization of Pseudomonas cepacia isolates from patients with cystic fibrosis. J Clin Microbiol 1984; 19: 291-3
24. Prince AS, Scott NB. Antibiotic resistance plasmids in Pseudomonas cepacia [abstract no. 992]. In: Program and abstracts of the 24th Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington, DC: American Society for Microbiology, 1984
25. Esanu JG, Schubert RHW. Taxonomy and nomenclature of Pseudomonas cepacia. Zentralbl Bakteriol Mikrobiol Hyg [A] 1973; 224: 478-83
26. Richard C, Monetil H, Mégraud F, Chatelain R, Laurent B. Caractères phénotypiques de 100 souches de Pseudomonas cepacia. Proposition d’un schema de biovars. Ann Biol Clin (Paris) 1981; 39: 9-15
27. Clark WA, Hollis DG, Weaver RE, Riley P. Identification of unusual pathogenic gram-negative aerobic and facultatively anaerobic bacteria. Atlanta: U.S. Department of Health and Human Services. Public Health Service. Centers for Disease Control, 1985
28. Stull TL, LiPuma JJ, Edlind TD. A broad-spectrum probe for molecular epidemiology of bacteria: ribosomal RNA. J Infect Dis 1988; 157: 280-5
29. Jonsson V. Proposal of a new species of Pseudomonas kingii. International Journal of Systematic Bacteriology 1970; 20: 255-7
30. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility tests (M2-A3-S1). Villanova, Pa: National Committee for Clinical Laboratory Standards, 1983
31. Martone WJ, Tablan OC, Jarvis WR. The epidemiology of epidemic Pseudomonas cepacia infections. Eur J Epidemiol 1987; 3: 222-32
32. Jarvis WR, Tablan OC, Martone WJ, Olson D, Hughes JM. The epidemiology of nosocomial Pseudomonas cepacia infections: endemic infections. Eur J Epidemiol 1987; 3: 233-6